XML 81 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Common Stock (Tables)
6 Months Ended
Oct. 31, 2013
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
      Six Months Ended  
      October 31, 2013     October 31, 2012  
  Risk-free interest rate   1.31%     0.62%  
  Expected volatility   78.94%     74.47%  
  Expected term   3.7 years     3.7 years  
  Dividend yield   0%     0%  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
      Weighted Average  
      Number of     Exercise Price  
      Options     per Share  
  Outstanding at April 30, 2013   3,930,818     $1.33  
  Granted   1,055,000     $1.67  
  Exercised   (231,655 )   $0.47  
  Forfeited/Cancelled   (18,604 )   $1.86  
  Expired   (40,000 )   $0.47  
  Outstanding at October 31, 2013   4,695,559     $1.45  
               
  Exercisable at October 31, 2013   2,682,368     $1.14  
  Exercisable at April 30, 2013   2,677,887     $1.00  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]
    Number of     Aggregate              Number of     Aggregate  
    Options     Intrinsic           Options     Intrinsic  
Exercise Price   Outstanding        Value     Expiry Date     Exercisable     Value  
$0.44   227,541   $ 172,704     December 15, 2013     227,541   $ 172,704  
$0.47   173,270     126,314     January 1, 2014 to September 26, 2016     173,270     126,314  
$0.60   388,873     232,935     December 14, 2014     372,527     223,144  
$0.62   850,000     492,150     April 17, 2014     850,000     492,150  
$1.41   100,000         October 1, 2018          
$1.44   250,000         September 12, 2018          
$1.53   200,000         August 29, 2018          
$1.70   750,000         December 14, 2016     343,749      
$1.88   30,000         December 13, 2017     6,250      
$1.90   916,875         December 14, 2015 to July 25, 2018     290,832      
$2.00   12,000         December 31, 2014 to February 28, 2015     12,000      
$2.15   240,000         September 7, 2016     240,000      
$2.26   200,000         March 14, 2018     37,302      
$2.27   52,000         March 10, 2016     33,584      
$2.90   305,000         July 19, 2017     95,313      
 October 31, 2013   4,695,559   $ 1,024,103           2,682,368   $ 1,014,312  
                               
 April 30, 2013   3,930,818   $ 2,636,687           2,677,887   $ 2,464,253  
Schedule of Nonvested Performance-based Units Activity [Table Text Block]
            Weighted  
      Number of     Average Grant  
      Options     Date Fair Value  
 

Non-vested options at April 30, 2013

  1,252,931     $1.09  
 

Granted

  1,055,000     $0.89  
 

Vested

  (285,053 )   $0.98  
 

Cancelled/Forfeited

  (9,687 )   $1.08  
 

Non-vested options at October 31, 2013

  2,013,191     $1.00  
Schedule of Employee and Non-Employee Service Share-based Compensation Allocation of Recognized Period Costs [Table Text Block]
      Three Months Ended     Six Months Ended  
      October 31,     October 31,  
      2013     2012     2013     2012  
  Cost of sales $ 18,285   $ 8,797   $ 26,838   $ 17,636  
  Sales and marketing   107,933     73,072     197,273     127,007  
  Research and development   15,851     10,531     24,537     21,247  
  General and administrative   37,083     55,100     70,570     111,043  
  Total stock-option based compensation $ 179,152   $ 147,500   $ 319,218   $ 276,933  
Schedule of Stockholders' Equity Note, Warrant Liability [Table Text Block]
      October 31,     April 30,  
      2013     2013  
 

Opening balance at the beginning of the period/year

$ 93,057   $ 2,026,944  
 

Fair value of warrant liability, at issuance

       
 

Change in fair value of warrant liability

  (93,057 )   (1,753,368 )
 

Fair value of warrants exercised during the period/year

      (180,519 )
 

Fair value of warrant liability at end of period/year

$   –   $ 93,057  
Schedule of Stockholders' Equity Note, Warrants or Rights, Valuation Assumptions [Table Text Block]
            As at the date of
    As at   As at   issuance
    October 31, 2013   April 30, 2013   June 14, 2011
  Risk-free interest rate   0.11%   1.60%
  Expected volatility   70%   70%
  Expected term   0.12 years   1.5 years to 2 years
  Dividend yield   0%   0%
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block]
      Number of     Weighted Average        
      Warrants     Exercise Price     Expiry Dates  
                     
  Warrants at April 30, 2013   2,248,399     2.57     June 14, 2013 to June 19, 2014  
  Granted            
  Exercised            
  Expired   (1,515,899 )   2.25     June 14, 2013  
  Warrants at October 31, 2013   732,500     3.25     June 19, 2014  
Schedule of Stockholders Equity Deferred Share Unit Plan [Table Text Block]
            Weighted Average  
            Grant Date Fair  
      Number of DSU’s     Value Per Unit  
 

DSUs outstanding at April 30, 2013

  1,643,119     $1.02  
 

Granted

  191,066     $1.90  
 

Conversions

  (73,334 )   $1.00  
 

DSUs outstanding at October 31, 2013

  1,760,851     $1.10  
Schedule of Stockholders Equity Non Vested Deferred Share Units [Table Text Block]
            Weighted Average  
            Grant Date Fair  
      Number of DSU’s     Value Per Unit  
 

Non-vested DSUs at April 30, 2013

  207,444     $1.98  
 

Granted

  191,066     $1.90  
 

Vested

  (227,048 )   $1.79  
 

Non-vested DSUs at October 31, 2013

  171,462     $2.19  
Schedule of Allocation of Share Based Compensation Costs for Deferred Share Units [Table Text Block]
      Three Months Ended     Six Months Ended  
      October 31,     October 31,  
      2013     2012     2013     2012  
  Sales and marketing $ 6,667   $ 4,167   $ 13,334   $ 8,334  
  Research and development   2,082     2,082     4,164     2,354  
  General and administrative   74,592     60,856     300,327     323,754  
  Total DSU-based compensation $ 83,341   $ 67,105   $ 317,825   $ 334,442